SlideShare a Scribd company logo
Wafik S. El-Deiry, M.D. Ph.D. 
Editor-in-Chief 
4-16-11
• 1st issue published January 1, 2002 
• Publisher: Landes BioScience 
• Founding Editor-in-Chief: Wafik S. El-Deiry 
• Indexed in PubMed, Index Medicus 
• Reviewed by Nature in 2002 and by JAMA in 
2004 
• Online and print version 
• Routine screening for plagiarism 
• Currently publishing 24 issues per year
AFGHANISTAN 
1% 
AUSTRIA 
1% BELGIUM 
1% 
BRAZIL 
1% 
CANADA 
3% 
CHINA 
5% 
DENMARK 
1% 
FRANCE 
1% 
GERMANY 
3% 
INDIA 
2% 
ITALY 
2% 
WORLDWIDE CIRCULATION 
JAPAN 
1% 
NETHERLANDS 
KOREA, 
REPUBLIC OF 
3% 
1% 
SLOVAKIA 
NORWAY 
1% 
1% 
SINGAPORE 
1% 
SPAIN 
1% 
UNITED STATES 
72% 
UNITED KINGDOM 
SWITZERLAND 
1% 
1% 
AFGHANISTAN 
AUSTRIA 
BELGIUM 
BRAZIL 
CANADA 
CHINA 
DENMARK 
FRANCE 
GERMANY 
INDIA 
ITALY 
JAPAN 
KOREA, REPUBLIC OF 
NETHERLANDS 
NORWAY 
SINGAPORE 
SLOVAKIA 
SPAIN 
SWITZERLAND 
UNITED KINGDOM
COUNTRIES AND LABORATORIES OF ORIGIN OF MANUSCRIPTS REPORT 
ORIGINAL MANUSCRIPTS SUBMITTED DURING JANUARY 1, 2004-APRIL 13, 2011 
Turkey 1% 
ARGENTINA ARMENIA 
AUSTRALIA AUSTRIA 
BELGIUM BRAZIL 
CHILE CHINA 
COLOMBIA CROATIA 
CUBA CZECH REPUBLIC 
DENMARK EGYPT 
FRANCE GERMANY 
HONG KONG HUNGARY 
INDIA INDONESIA 
IRELAND ISRAEL 
JAPAN KOREA (SOUTH), REPUBLIC OF 
KUWAIT MALAYSIA 
MEXICO NETHERLANDS 
NEW ZEALAND PAKISTAN 
PHILIPPINES POLAND 
PORTUGAL SAUDI ARABIA 
SERBIA AND MONTENEGRO SLOVAK REPUBLIC 
SLOVENIA SOUTH AFRICA 
SPAIN SRI LANKA 
SUDAN UNKNOWN 
CANADA FINLAND 
GREECE IRAN 
ITALY LEBANON 
MACAU NORWAY 
ROMANIA RUSSIA 
SINGAPORE SWEDEN 
SWITZERLAND TAIWAN 
THAILAND TUNISIA 
TURKEY UNITED ARAB EMIRATES 
UNITED KINGDOM UNITED STATES OF AMERICA 
URUGUAY VENEZUELA
255 
Growth of CBT Submissions 
355 
2005–2010 
378 
535 523 
607 
700 
600 
500 
400 
300 
200 
100 
0 
2005 2006 2007 2008 2009 2010 
NUMBER OF SUBMISSIONS 
YEAR
• Large distinguished Editorial Board 
• Broad interest in field of cancer 
• High interest in cancer biology, TME, 
signaling, translational research, drug 
development, new technologies 
• Rapid reviews; typical decisions in 2-3 wks 
• Responsive to colleagues 
• Impact is highest priority 
• ~2000 downloads per week
• Commentaries 
• Reviews 
• Bedside-to-Bench Reports 
• Journal Club; Book Reviews 
• Focused Review Series 
• Research Philosophy/Profiles & Legacies 
• Meeting Reports 
• Consider sending your next high impact 
paper to CB&T
129 issues published 
by April 2011 
View beautiful covers 
online 
Cancer Biology 
& Therapy
CBT On-Line Welcome Message 12-10 
http://www.landesbioscience.com/journals/cbt 
/
2011 
See the journal on FaceBook 
Read articles on your iPAD 
http://www.landesbioscience.com/journals/cbt 
/
Questions? 
http://www.landesbioscience.com/journals/cbt 
/

More Related Content

Viewers also liked

TenthWindow Company Portfolio
TenthWindow Company PortfolioTenthWindow Company Portfolio
TenthWindow Company Portfolio
Ghasem Vahedi
 
4 Ways to Defend Against Internal Attacks
4 Ways to Defend Against Internal Attacks4 Ways to Defend Against Internal Attacks
4 Ways to Defend Against Internal Attacks
Kevin O'Connor
 
Uts smplb c kls vii smt 2, 2013/2014 pendidikan agama islam
Uts smplb c  kls vii smt 2, 2013/2014 pendidikan agama islamUts smplb c  kls vii smt 2, 2013/2014 pendidikan agama islam
Uts smplb c kls vii smt 2, 2013/2014 pendidikan agama islamM. ALI AMIRUDDIN
 
Soal uts smt 2 pkn kls vii smplb c 2013/2014
Soal uts smt 2 pkn kls vii smplb c 2013/2014Soal uts smt 2 pkn kls vii smplb c 2013/2014
Soal uts smt 2 pkn kls vii smplb c 2013/2014M. ALI AMIRUDDIN
 

Viewers also liked (7)

TenthWindow Company Portfolio
TenthWindow Company PortfolioTenthWindow Company Portfolio
TenthWindow Company Portfolio
 
Uu nomor 8 tahun 2012
Uu nomor 8 tahun 2012Uu nomor 8 tahun 2012
Uu nomor 8 tahun 2012
 
4 Ways to Defend Against Internal Attacks
4 Ways to Defend Against Internal Attacks4 Ways to Defend Against Internal Attacks
4 Ways to Defend Against Internal Attacks
 
MKSAP 16 7-18-15
MKSAP 16 7-18-15MKSAP 16 7-18-15
MKSAP 16 7-18-15
 
Uts smplb c kls vii smt 2, 2013/2014 pendidikan agama islam
Uts smplb c  kls vii smt 2, 2013/2014 pendidikan agama islamUts smplb c  kls vii smt 2, 2013/2014 pendidikan agama islam
Uts smplb c kls vii smt 2, 2013/2014 pendidikan agama islam
 
Soal uts smt 2 pkn kls vii smplb c 2013/2014
Soal uts smt 2 pkn kls vii smplb c 2013/2014Soal uts smt 2 pkn kls vii smplb c 2013/2014
Soal uts smt 2 pkn kls vii smplb c 2013/2014
 
Nick Vujicic
Nick VujicicNick Vujicic
Nick Vujicic
 

More from Wafik El-Deiry, MD PhD FACP

ASCO heterogeneity presentation El-Deiry 6-4-17
ASCO heterogeneity presentation El-Deiry 6-4-17ASCO heterogeneity presentation El-Deiry 6-4-17
ASCO heterogeneity presentation El-Deiry 6-4-17
Wafik El-Deiry, MD PhD FACP
 
Paving the Way for Personalized Therapy | Fox Chase Cancer Center - Philadelp...
Paving the Way for Personalized Therapy | Fox Chase Cancer Center - Philadelp...Paving the Way for Personalized Therapy | Fox Chase Cancer Center - Philadelp...
Paving the Way for Personalized Therapy | Fox Chase Cancer Center - Philadelp...Wafik El-Deiry, MD PhD FACP
 
US Senator Pat Toomey visits El-Deiry Lab at Penn State 4-23-12
US Senator Pat Toomey visits El-Deiry Lab at Penn State 4-23-12US Senator Pat Toomey visits El-Deiry Lab at Penn State 4-23-12
US Senator Pat Toomey visits El-Deiry Lab at Penn State 4-23-12Wafik El-Deiry, MD PhD FACP
 
Targeted translational RFA for Rare tumor subtypes and exceptional responders...
Targeted translational RFA for Rare tumor subtypes and exceptional responders...Targeted translational RFA for Rare tumor subtypes and exceptional responders...
Targeted translational RFA for Rare tumor subtypes and exceptional responders...Wafik El-Deiry, MD PhD FACP
 
Translational Medicine Poster 8-12-15 revised agenda
Translational Medicine Poster 8-12-15 revised agendaTranslational Medicine Poster 8-12-15 revised agenda
Translational Medicine Poster 8-12-15 revised agendaWafik El-Deiry, MD PhD FACP
 
Profiles_in_Oncology_Social_Media__Wafik_El_Deiry,.19
Profiles_in_Oncology_Social_Media__Wafik_El_Deiry,.19Profiles_in_Oncology_Social_Media__Wafik_El_Deiry,.19
Profiles_in_Oncology_Social_Media__Wafik_El_Deiry,.19Wafik El-Deiry, MD PhD FACP
 
p21 mechanism slide
p21 mechanism slidep21 mechanism slide
p21 mechanism slide
Wafik El-Deiry, MD PhD FACP
 

More from Wafik El-Deiry, MD PhD FACP (13)

ASCO heterogeneity presentation El-Deiry 6-4-17
ASCO heterogeneity presentation El-Deiry 6-4-17ASCO heterogeneity presentation El-Deiry 6-4-17
ASCO heterogeneity presentation El-Deiry 6-4-17
 
MKSAP 17 CME credits 8-24-16
MKSAP 17 CME credits 8-24-16MKSAP 17 CME credits 8-24-16
MKSAP 17 CME credits 8-24-16
 
Paving the Way for Personalized Therapy | Fox Chase Cancer Center - Philadelp...
Paving the Way for Personalized Therapy | Fox Chase Cancer Center - Philadelp...Paving the Way for Personalized Therapy | Fox Chase Cancer Center - Philadelp...
Paving the Way for Personalized Therapy | Fox Chase Cancer Center - Philadelp...
 
Triumph El-Deiry July 2011
Triumph El-Deiry July 2011Triumph El-Deiry July 2011
Triumph El-Deiry July 2011
 
Triumph El-Deiry July 2011
Triumph El-Deiry July 2011Triumph El-Deiry July 2011
Triumph El-Deiry July 2011
 
Triumph El-Deiry July 2011
Triumph El-Deiry July 2011Triumph El-Deiry July 2011
Triumph El-Deiry July 2011
 
US Senator Pat Toomey visits El-Deiry Lab at Penn State 4-23-12
US Senator Pat Toomey visits El-Deiry Lab at Penn State 4-23-12US Senator Pat Toomey visits El-Deiry Lab at Penn State 4-23-12
US Senator Pat Toomey visits El-Deiry Lab at Penn State 4-23-12
 
Targeted translational RFA for Rare tumor subtypes and exceptional responders...
Targeted translational RFA for Rare tumor subtypes and exceptional responders...Targeted translational RFA for Rare tumor subtypes and exceptional responders...
Targeted translational RFA for Rare tumor subtypes and exceptional responders...
 
Translational Medicine Poster 8-12-15 revised agenda
Translational Medicine Poster 8-12-15 revised agendaTranslational Medicine Poster 8-12-15 revised agenda
Translational Medicine Poster 8-12-15 revised agenda
 
AACR 2015
AACR 2015AACR 2015
AACR 2015
 
GI ASCO single slide per page 1-17-15
GI ASCO single slide per page 1-17-15GI ASCO single slide per page 1-17-15
GI ASCO single slide per page 1-17-15
 
Profiles_in_Oncology_Social_Media__Wafik_El_Deiry,.19
Profiles_in_Oncology_Social_Media__Wafik_El_Deiry,.19Profiles_in_Oncology_Social_Media__Wafik_El_Deiry,.19
Profiles_in_Oncology_Social_Media__Wafik_El_Deiry,.19
 
p21 mechanism slide
p21 mechanism slidep21 mechanism slide
p21 mechanism slide
 

CBT 4-16-11

  • 1. Wafik S. El-Deiry, M.D. Ph.D. Editor-in-Chief 4-16-11
  • 2.
  • 3. • 1st issue published January 1, 2002 • Publisher: Landes BioScience • Founding Editor-in-Chief: Wafik S. El-Deiry • Indexed in PubMed, Index Medicus • Reviewed by Nature in 2002 and by JAMA in 2004 • Online and print version • Routine screening for plagiarism • Currently publishing 24 issues per year
  • 4. AFGHANISTAN 1% AUSTRIA 1% BELGIUM 1% BRAZIL 1% CANADA 3% CHINA 5% DENMARK 1% FRANCE 1% GERMANY 3% INDIA 2% ITALY 2% WORLDWIDE CIRCULATION JAPAN 1% NETHERLANDS KOREA, REPUBLIC OF 3% 1% SLOVAKIA NORWAY 1% 1% SINGAPORE 1% SPAIN 1% UNITED STATES 72% UNITED KINGDOM SWITZERLAND 1% 1% AFGHANISTAN AUSTRIA BELGIUM BRAZIL CANADA CHINA DENMARK FRANCE GERMANY INDIA ITALY JAPAN KOREA, REPUBLIC OF NETHERLANDS NORWAY SINGAPORE SLOVAKIA SPAIN SWITZERLAND UNITED KINGDOM
  • 5. COUNTRIES AND LABORATORIES OF ORIGIN OF MANUSCRIPTS REPORT ORIGINAL MANUSCRIPTS SUBMITTED DURING JANUARY 1, 2004-APRIL 13, 2011 Turkey 1% ARGENTINA ARMENIA AUSTRALIA AUSTRIA BELGIUM BRAZIL CHILE CHINA COLOMBIA CROATIA CUBA CZECH REPUBLIC DENMARK EGYPT FRANCE GERMANY HONG KONG HUNGARY INDIA INDONESIA IRELAND ISRAEL JAPAN KOREA (SOUTH), REPUBLIC OF KUWAIT MALAYSIA MEXICO NETHERLANDS NEW ZEALAND PAKISTAN PHILIPPINES POLAND PORTUGAL SAUDI ARABIA SERBIA AND MONTENEGRO SLOVAK REPUBLIC SLOVENIA SOUTH AFRICA SPAIN SRI LANKA SUDAN UNKNOWN CANADA FINLAND GREECE IRAN ITALY LEBANON MACAU NORWAY ROMANIA RUSSIA SINGAPORE SWEDEN SWITZERLAND TAIWAN THAILAND TUNISIA TURKEY UNITED ARAB EMIRATES UNITED KINGDOM UNITED STATES OF AMERICA URUGUAY VENEZUELA
  • 6. 255 Growth of CBT Submissions 355 2005–2010 378 535 523 607 700 600 500 400 300 200 100 0 2005 2006 2007 2008 2009 2010 NUMBER OF SUBMISSIONS YEAR
  • 7.
  • 8. • Large distinguished Editorial Board • Broad interest in field of cancer • High interest in cancer biology, TME, signaling, translational research, drug development, new technologies • Rapid reviews; typical decisions in 2-3 wks • Responsive to colleagues • Impact is highest priority • ~2000 downloads per week
  • 9. • Commentaries • Reviews • Bedside-to-Bench Reports • Journal Club; Book Reviews • Focused Review Series • Research Philosophy/Profiles & Legacies • Meeting Reports • Consider sending your next high impact paper to CB&T
  • 10. 129 issues published by April 2011 View beautiful covers online Cancer Biology & Therapy
  • 11. CBT On-Line Welcome Message 12-10 http://www.landesbioscience.com/journals/cbt /
  • 12. 2011 See the journal on FaceBook Read articles on your iPAD http://www.landesbioscience.com/journals/cbt /